383 related articles for article (PubMed ID: 27669680)
1. Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation.
Chang L; Chey WD; Drossman D; Losch-Beridon T; Wang M; Lichtlen P; Mareya S
Aliment Pharmacol Ther; 2016 Nov; 44(10):1114-1122. PubMed ID: 27669680
[TBL] [Abstract][Full Text] [Related]
2. Lubiprostone Is Effective in the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Li F; Fu T; Tong WD; Liu BH; Li CX; Gao Y; Wu JS; Wang XF; Zhang AP
Mayo Clin Proc; 2016 Apr; 91(4):456-68. PubMed ID: 27046523
[TBL] [Abstract][Full Text] [Related]
3. Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel Syndrome with Constipation.
Brenner DM; Sharma A; Rao SSC; Laitman AP; Heimanson Z; Allen C; Sayuk GS
Dig Dis Sci; 2024 May; 69(5):1731-1738. PubMed ID: 38594429
[TBL] [Abstract][Full Text] [Related]
4. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
Chey WD; Lembo AJ; Lavins BJ; Shiff SJ; Kurtz CB; Currie MG; MacDougall JE; Jia XD; Shao JZ; Fitch DA; Baird MJ; Schneier HA; Johnston JM
Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437
[TBL] [Abstract][Full Text] [Related]
5. Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis Using New End Points.
Lacy BE; Chang L; Rao SSC; Heimanson Z; Sayuk GS
Clin Ther; 2023 Mar; 45(3):198-209. PubMed ID: 36922331
[TBL] [Abstract][Full Text] [Related]
6. Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions.
Yang Y; Fang J; Guo X; Dai N; Shen X; Yang Y; Sun J; Bhandari BR; Reasner DS; Cronin JA; Currie MG; Johnston JM; Zeng P; Montreewasuwat N; Chen GZ; Lim S
J Gastroenterol Hepatol; 2018 May; 33(5):980-989. PubMed ID: 29319191
[TBL] [Abstract][Full Text] [Related]
7.
Cayzeele-Decherf A; Pélerin F; Leuillet S; Douillard B; Housez B; Cazaubiel M; Jacobson GK; Jüsten P; Desreumaux P
World J Gastroenterol; 2017 Jan; 23(2):336-344. PubMed ID: 28127207
[TBL] [Abstract][Full Text] [Related]
8. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.
Videlock EJ; Cheng V; Cremonini F
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388
[TBL] [Abstract][Full Text] [Related]
9. Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial.
Chey WD; Lembo AJ; Rosenbaum DP
Am J Gastroenterol; 2017 May; 112(5):763-774. PubMed ID: 28244495
[TBL] [Abstract][Full Text] [Related]
10. Lubiprostone: RU 0211, SPI 0211.
Drugs R D; 2005; 6(4):245-8. PubMed ID: 15991886
[TBL] [Abstract][Full Text] [Related]
11. Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study.
Hawrelak JA; Myers SP
J Altern Complement Med; 2010 Oct; 16(10):1065-71. PubMed ID: 20954962
[TBL] [Abstract][Full Text] [Related]
12. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
[TBL] [Abstract][Full Text] [Related]
13. Systematic review with meta-analysis: lubiprostone efficacy on the treatment of patients with constipation.
Passos MDCF; Takemoto MLS; Corradino GC; Guedes LS
Arq Gastroenterol; 2020; 57(4):498-506. PubMed ID: 33331483
[TBL] [Abstract][Full Text] [Related]
14. Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints.
Quigley EM; Tack J; Chey WD; Rao SS; Fortea J; Falques M; Diaz C; Shiff SJ; Currie MG; Johnston JM
Aliment Pharmacol Ther; 2013 Jan; 37(1):49-61. PubMed ID: 23116208
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation.
Johanson JF; Drossman DA; Panas R; Wahle A; Ueno R
Aliment Pharmacol Ther; 2008 Apr; 27(8):685-96. PubMed ID: 18248656
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis.
Black CJ; Burr NE; Quigley EMM; Moayyedi P; Houghton LA; Ford AC
Gastroenterology; 2018 Dec; 155(6):1753-1763. PubMed ID: 30144426
[TBL] [Abstract][Full Text] [Related]
17. Systematic review and network meta-analysis: efficacy of licensed drugs for abdominal bloating in irritable bowel syndrome with constipation.
Nelson AD; Black CJ; Houghton LA; Lugo-Fagundo NS; Lacy BE; Ford AC
Aliment Pharmacol Ther; 2021 Jul; 54(2):98-108. PubMed ID: 34114657
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials.
Brenner DM; Fogel R; Dorn SD; Krause R; Eng P; Kirshoff R; Nguyen A; Crozier RA; Magnus L; Griffin PH
Am J Gastroenterol; 2018 May; 113(5):735-745. PubMed ID: 29545635
[TBL] [Abstract][Full Text] [Related]
19. Lubiprostone--a novel treatment for irritable bowel syndrome with constipation.
Owen RT
Drugs Today (Barc); 2008 Sep; 44(9):645-52. PubMed ID: 19137119
[TBL] [Abstract][Full Text] [Related]
20. A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.
Jamal MM; Adams AB; Jansen JP; Webster LR
Am J Gastroenterol; 2015 May; 110(5):725-32. PubMed ID: 25916220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
